Search the Newsreel

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

Silicon Labs (SLAB) Stock Carries A Premium As Losses Persist

Silicon Laboratories (SLAB) stock remains highly valued despite continuing to report net losses and negative basic earnings per share. While Q2 2026 results showed narrowed losses and increased revenue driven by IoT segments, concerns persist regarding the company's profitability and execution risk, especially with …

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

Cabot Sets 4.950% Interest on $350M Senior Notes Due 2029

Cabot Corporation has priced a public offering of $350 million in 4.950% senior unsecured notes due 2029, with interest to be paid semiannually. The offering is expected to close on August 21, 2026, and the net proceeds will primarily be used to repay existing …

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABBOTT LABORATORIES AKTIE: AI-Analysen, Prognose & Kursziel

Dolby Laboratories (DLB) VP Nicholson sells 1,348 Class A shares at $62.04

Ryan Nicholson, VP, CAO and Corporate Controller of Dolby Laboratories (DLB), sold 1,348 shares of Class A common stock at $62.04 per share on August 10, 2026. Following this transaction, Nicholson directly holds 35,636 shares, which includes 19,303 shares of restricted stock units that …

Abbott Laboratories stock outperforms competitors on strong trading day

Shares of Abbott Laboratories (ABT) rose 1.08% to $110.91, marking its third consecutive day of gains. This performance occurred on a mixed trading day where the S&P 500 Index increased by 0.26% and the Dow Jones Industrial Average fell by 0.04%. The stock's positive …

Labcorp president & CEO Adam Schechter sells $1.5m in company stock

Adam H. Schechter, President & CEO of Labcorp Holdings Inc., sold 4,669 shares of company stock for approximately $1.5 million. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan. This transaction occurred as LH stock traded near its 52-week high, following …

Insider Selling: Labcorp (NYSE:LH) CEO Sells 4,669 Shares of Stock

Labcorp CEO Adam Schechter sold 4,669 shares of company stock for approximately $1.50 million under a pre-arranged trading plan, reducing his total ownership by 4.35%. This sale occurred while Labcorp shares traded near their 52-week high, following strong quarterly earnings that surpassed analyst expectations. …

The Abbott Big Ten $1 Million Blood Drive is Back

The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …

Securities Fraud Investigation Into Taboola.com Ltd. (TBLA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz is continuing its investigation into Taboola.com Ltd. (TBLA) for potential violations of federal securities laws. This follows a 27.50% drop in Taboola's stock price on August 5, 2026, after the company reported second-quarter earnings below guidance, attributing …

Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced …

Ind-Swift Laboratories Sets Q1 FY27 Earnings Call for August 17

Taboola (TBLA) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wed, Aug. 5, 2026 at 08:30 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Aadam Anwar Founder and CEO - Adam Singolda CFO - Steve Walker Full Conference Call Transcript Operator: Good day, and thank you for …

What Abbott Laboratories (ABT)'s AI-Powered Google Health Partnership Means For Shareholders

Abbott Laboratories has partnered with Google Health to integrate glucose insights from its Lingo biowearable into the Google Health app, using AI for personalized metabolic health coaching and unified wellness data. This collaboration includes a large-scale metabolic health study, potentially supporting Abbott's diabetes franchise …

Charles River Laboratories stock hits 52-week high at $285.13 By Investing.com

Charles River Laboratories International Inc. (CRL) stock has reached a 52-week high of $285.13, reflecting an 83.28% increase over the past year and a 41.4% year-to-date return. This surge follows strong second-quarter earnings that surpassed analyst expectations and led to increased price targets from …

Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Todd Spencer Chief Executive Officer - Birgit Girshick Executive Vice President and Chief Financial Officer - Glenn Coleman Full Conference Call Transcript …

CAPLIPOINT: Strong revenue growth, margin expansion, and strategic investments drive future outlook

Every 2 Seconds, Someone in the U.S. Needs Blood as Abbott Drive Returns

Abbott (NYSE: ABT) and the Big Ten Conference have relaunched their "We Give Blood" nationwide competition to address a critical blood supply crisis in the U.S. All 18 Big Ten universities will compete to generate the most blood donations, with Abbott awarding $1 million …

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

CAPLIPOINT: 20% revenue growth, strong margins, and major capacity expansion drive future outlook

Mesa Laboratories (MLAB) Stock Jumps As Margin Gains Meet Backlog Doubts

Mesa Laboratories' stock jumped 9.5% after its Q1 2027 earnings, with investors focusing on improved profitability despite modest revenue growth. Gross margins increased, and cash generation was solid, but net income and EPS declined year-on-year. The company faces risks from backlog issues and customer …

Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Labcorp (LH) Stock Looks About Right On Raised Full Year Guidance

Labcorp (LH) stock appears to be fairly valued according to Discounted Cash Flow and P/E ratio analyses, following a 54.1% increase over the last three years and a recent raise in full-year guidance. The intrinsic value estimate is close to the current share price, …

Caplin Point Laboratories fixes Sept 18 record date for 35th AGM

Charles River Laboratories International, Inc. $CRL Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in Charles River Laboratories International (NYSE: CRL) by 98.4% in the first quarter, selling over 151,000 shares. Despite this, analyst sentiment remains largely positive, with a consensus "Moderate Buy" rating and a $255.65 average price target. The …

Idexx Laboratories (IDXX) Receives a Buy from Barclays

Asymchem Labs Sets Board Meeting to Approve 2026 Interim Results

CAPLIPOINT: Q1 FY27 revenue grew 20.7% YoY to ₹644 Crores, with PAT up 18.8% to ₹179 Crores

CAPLIPOINT: Q1 FY27 delivered double-digit revenue and profit growth, with strong expansion in key markets

Butensky & Cohen Financial Security Inc. Purchases 9,277 Shares of Abbott Laboratories $ABT

Butensky & Cohen Financial Security Inc. increased its stake in Abbott Laboratories (NYSE:ABT) by 26.9% in the second quarter, acquiring an additional 9,277 shares to own a total of 43,809 shares valued at $3.98 million. This move comes as Abbott Laboratories reported strong quarterly …

Unichem Laboratories shareholders approve Bhattacharyya reappointment at AGM

Valiant Laboratories Q1 Results: Net profit jumps 422% YoY to ₹9.48 cr

Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Labcorp Holdings Inc. (NYSE:LH) has received a consensus "Moderate Buy" rating from twelve brokerages, with an average 12-month price target of $330.00. The company recently surpassed quarterly earnings expectations with $4.99 EPS and $3.73 billion in revenue, and declared a quarterly dividend of $0.72 …